From: Dissemination of public health research to prevent non-communicable diseases: a scoping review
 |  | Qualitative/Mixed methods N = 52 n (%) | Quantitative studies N = 40 n (%) | Experimental N = 15 n (%) | Total n |
---|---|---|---|---|---|
Country* | Canada | 22 (42) | 8 (20) | 3 (20) | 33 |
 | United States | 9 (17) | 22 (55) | 8 (53) | 39 |
 | United Kingdom | 6 (12) | 2 (5) | 4 (27) | 12 |
 | Australia | 8 (15) | 3 (8) | 1 (7) | 12 |
 | Low and middle income countries | 6 (12) | 3 (8) | 0 (0) | 9 |
 | Other high income countries | 3 (6) | 3 (8) | 2 (13) | 8 |
 | Country/s not specified | 3 (6) | 1 (3) | 0 (0) | 4 |
Sample size (either of respondents or organisations/cases if not reported) | < 250 | 46 (88) | 21 (53) | 6 (40) | 73 |
 | ≥250 | 4 (8) | 15 (38) | 9 (60) | 28 |
 | Unclear/not reported | 2 (4) | 4 (10) | 0 (0) | 6 |
Focus Area of disseminated information* | Physical Activity/Diet/Obesity | 20 (38) | 20 (50) | 4 (27) | 44 |
 | Cancer screening | 2 (4) | 2 (5) | 3 (20) | 7 |
 | Substance use | 9 (17) | 10 (25) | 4 (27) | 23 |
 | Mental health | 6 (12) | 3 (8) | 2 (13) | 11 |
 | Public health (general) | 17 (33) | 7 (18) | 0 (0) | 24 |
 | Cardiovascular risk factors (e.g. hypertension) | 1 (2) | 3 (8) | 0 (0) | 4 |
 | Other (including not explicitly specified) | 6 (12) | 2 (5) | 2 (13) | 10 |
Source (could be evidence producer or disseminator)*# | Researchers/Academics/Scientific Societies | 23 (44) | 23 (58) | 12 (80) | 58 |
 | Government body/health department | 18 (35) | 11 (28) | 2 (13) | 31 |
 | Guideline development groups | 7 (13) | 7 (18) | 2 (13) | 16 |
 | Professional Societies | 3 (6) | 4 (10) | 2 (13) | 9 |
 | Other | 18 (35) | 11 (28) | 4 (27) | 33 |
Message# | Evidence based program/practice (for interventions or programs) | 2 (4) | 12 (30) | 6 (40) | 20 |
 | Guidelines (guidelines, codes or tools) | 7 (13) | 8 (20) | 4 (27) | 19 |
 | Knowledge/research evidence/study findings including summaries | 21 (40) | 20 (50) | 5 (33) | 46 |
Channel*^ | Academic outputs (i.e.,journal articles, conferences, reports) | 25 (48) | 14 (35) | 0 (0) | 39 |
 | Policy briefs/summaries | 13 (25) | 2 (5) | 1 (7) | 16 |
 | Information brochures/pamphlets/written materials | 9 (17) | 14 (35) | 8 (53) | 31 |
 | Websites/infographics | 17 (33) | 17 (43) | 3 (20) | 37 |
 | One-on-one meetings (in person or technology enabled) | 12 (23) | 14 (35) | 5 (33) | 31 |
 | Training/workshop/presentations | 19 (37) | 23 (58) | 6 (40) | 48 |
 | Media (traditional or social) | 13 (25) | 12 (30) | 1 (7) | 26 |
 | Decision support tools or resources | 6 (12) | 16 (40) | 5 (33) | 27 |
 | Other | 22 (42) | 12 (30) | 4 (27) | 38 |
Intended Audience* | Practitioners | 27 (52) | 24 (60) | 10 (67) | 61 |
 | Policymakers | 24 (46) | 13 (33) | 2 (13) | 39 |
 | Public Health managers/administrators | 23 (44) | 13 (33) | 2 (13) | 38 |
 | Community Decision Makers | 11 (21) | 10 (25) | 4 (27) | 25 |
 | General Public | 10 (19) | 7 (18) | 1 (7) | 18 |
 | Researchers | 12 (23) | 7 (18) | 0 (0) | 19 |
 | Others such as NGOs, advisory bodies | 18 (35) | 13 (33) | 1 (7) | 32 |
Outcomes* | Awareness | 9 (17) | 12 (30) | 5 (33) | 26 |
 | Reach | 9 (17) | 17 (43) | 2 (13) | 28 |
 | Attitudes | 14 (27) | 18 (45) | 4 (27) | 36 |
 | Knowledge | 11 (21) | 6 (15) | 4 (27) | 21 |
 | Intentions to adopt | 9 (17) | 12 (30) | 8 (53) | 29 |
 | Adoption/uptake | 22 (42) | 24 (60) | 11 (73) | 57 |
 | Preferences | 31 (60) | 8 (20) | 1 (7) | 40 |
 | Experiences of dissemination | 36 (69) | 15 (38) | 0 (0) | 51 |